Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Constitutive Activation of the Tumor Suppressor p53 in Hepatocytes Paradoxically Promotes Non–Cell Autonomous Liver Carcinogenesis
Yuki Makino, Hayato Hikita, Kenji Fukumoto, et al.
Cancer Research (2022) Vol. 82, Iss. 16, pp. 2860-2873
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Targeting p53 pathways: mechanisms, structures and advances in therapy
Haolan Wang, Ming Guo, Hudie Wei, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 379
Understanding the complexity of p53 in a new era of tumor suppression
Yanqing Liu, Zhenyi Su, Omid Tavana, et al.
Cancer Cell (2024) Vol. 42, Iss. 6, pp. 946-967
Open Access | Times Cited: 102
The DNA Damage Response and Inflammation in Cancer
Vanessa Klapp, Beatriz Álvarez-Abril, Giuseppe Leuzzi, et al.
Cancer Discovery (2023) Vol. 13, Iss. 7, pp. 1521-1545
Open Access | Times Cited: 55
Ferroptosis in hepatocellular carcinoma: from bench to bedside
Daolin Tang, Guido Kroemer, Rui Kang
Hepatology (2023) Vol. 80, Iss. 3, pp. 721-739
Closed Access | Times Cited: 28
p53/MicroRNA-34 axis in cancer and beyond
Wei Pan, Binshu Chai, Li Langping, et al.
Heliyon (2023) Vol. 9, Iss. 4, pp. e15155-e15155
Open Access | Times Cited: 24
Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment
Fusheng Zhang, Junchen Guo, Shengmiao Yu, et al.
Cancer Communications (2024) Vol. 44, Iss. 9, pp. 929-966
Open Access | Times Cited: 14
Immunotherapy in hepatocellular carcinoma: an overview of immune checkpoint inhibitors, drug resistance, and adverse effects
Xuan-Yu Gu, Jinlong Huo, Yu Zhiyong, et al.
ONCOLOGIE (2024) Vol. 26, Iss. 1, pp. 9-25
Open Access | Times Cited: 6
Spatial single-cell protein landscape reveals vimentinhigh macrophages as immune-suppressive in the microenvironment of hepatocellular carcinoma
Xinyao Qiu, Tao Zhou, Shuai Li, et al.
Nature Cancer (2024) Vol. 5, Iss. 10, pp. 1557-1578
Closed Access | Times Cited: 6
ZNF385A and ZNF346 Serve as Prognostic Biomarkers Associated with an Inflamed Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma
Qihang Peng, Jin Li, Qian Wu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3155-3155
Open Access | Times Cited: 14
Ginsenoside Rg5 inhibits lipid accumulation and hepatocyte apoptosis via the Notch1 signaling pathway in NASH mice
Na Li, Chenhui Zhu, Rongzhan Fu, et al.
Phytomedicine (2023) Vol. 124, pp. 155287-155287
Closed Access | Times Cited: 14
Tissue specificity and spatio-temporal dynamics of the p53 transcriptional program
Vinod Pant, Chang Sun, Guillermina Lozano
Cell Death and Differentiation (2023) Vol. 30, Iss. 4, pp. 897-905
Open Access | Times Cited: 13
p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme
Meng Jiao, Wei Qian, Zhenkun Yang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Aristolochic acids-hijacked p53 promotes liver cancer cell growth by inhibiting ferroptosis
Chunyu Hou, Yuhong Suo, Pan Lv, et al.
Acta Pharmacologica Sinica (2024)
Closed Access | Times Cited: 5
Hedgehog Signaling: Implications in Liver Pathophysiology
Rajesh Kumar Dutta, JiHye Jun, Kuo Du, et al.
Seminars in Liver Disease (2023) Vol. 43, Iss. 04, pp. 418-428
Closed Access | Times Cited: 11
Infectious viruses and neurodegenerative diseases: The mitochondrial defect hypothesis
Tianshi Jiang, Kaili Zhu, Gloria Kang, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 4
Closed Access | Times Cited: 4
Cellular senescence offers distinct immunological vulnerabilities in cancer
Lin Zhou, Boyang Ma, Marcus Ruscetti
Trends in cancer (2024)
Closed Access | Times Cited: 4
Integrative Transcriptomics Analysis Reveals Convergent Toxicological Effects of Perfluorooctanoic Acid and Perfluorooctane Sulfonate on Human Liver: Evidence from Multiple Models
Renjun Yang, Nuoya Yin, Francesco Faiola
Journal of Hazardous Materials (2025), pp. 138112-138112
Open Access
STAT3 is Activated by CTGF-mediated Tumor-stroma Cross Talk to Promote HCC Progression
Yuki Makino, Hayato Hikita, Seiya Kato, et al.
Cellular and Molecular Gastroenterology and Hepatology (2022) Vol. 15, Iss. 1, pp. 99-119
Open Access | Times Cited: 13
The role of transcription factors in the acquisition of the four latest proposed hallmarks of cancer and corresponding enabling characteristics
Maria P. Morgan, Ellen Finnegan, Sudipto Das
Seminars in Cancer Biology (2022) Vol. 86, pp. 1203-1215
Open Access | Times Cited: 9
Identification of MDM2 as a prognostic and immunotherapeutic biomarker in a comprehensive pan-cancer analysis: A promising target for breast cancer, bladder cancer and ovarian cancer immunotherapy
Jialiang Zheng, Fenglin Miao, Zhao Wang, et al.
Life Sciences (2023) Vol. 327, pp. 121832-121832
Closed Access | Times Cited: 5
Targeting transglutaminase 2 mediated exostosin glycosyltransferase 1 signaling in liver cancer stem cells with acyclic retinoid
Xian‐Yang Qin, Yutaka Furutani, Kento Yonezawa, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 6
Open Access | Times Cited: 5
The Theory of Carcino-Evo-Devo and Its Non-Trivial Predictions
Andrei P. Kozlov
Genes (2022) Vol. 13, Iss. 12, pp. 2347-2347
Open Access | Times Cited: 8
p53 Activation Paradoxically Causes Liver Cancer
Michelle Barton, Guillermina Lozano
Cancer Research (2022) Vol. 82, Iss. 16, pp. 2824-2825
Open Access | Times Cited: 8
Could senescence phenotypes strike the balance to promote tumor dormancy?
Fang-Yen Chiu, Raegan Kvadas, Zeinab Mheidly, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 1, pp. 143-160
Closed Access | Times Cited: 4
An updated review of a novel method for examining P53 mutations in different forms of cancer
Navid Shomali, Amin Kamrani, Hadi Nasiri, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154585-154585
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top